Q1 2024 Holdings
Filed 2024-05-15 | 22 holdings | $179.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $15.3M | 160,950 | 8.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $14.4M | 336,486 | 8.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $14.1M | 320,378 | 7.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.3M | 309,369 | 7.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $11.9M | 736,738 | 6.6% |
| Merus N V | COM | N5749R100 | $11.5M | 255,928 | 6.4% |
| Praxis Precision Medicines I(PRAX) | COM | 74006W207 | $9.7M | 159,486 | 5.4% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $9.4M | 1,001,452 | 5.2% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $9.2M | 547,036 | 5.1% |
| Geron Corp(GERN) | COM | 374163103 | $9.1M | 2,760,497 | 5.1% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $8.5M | 289,943 | 4.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $7.8M | 365,044 | 4.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $6.8M | 250,000 | 3.8% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $6.5M | 216,968 | 3.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $6.3M | 559,035 | 3.5% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $6.2M | 1,003,741 | 3.5% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $5.8M | 270,559 | 3.2% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $3.8M | 420,000 | 2.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $3.6M | 801,437 | 2.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $3.6M | 394,773 | 2.0% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $2.0M | 1,059,582 | 1.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.0M | 725,951 | 0.6% |